Brief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
20/10/2026 22:57
BRIEF-Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science Oct 20 (Reuters) - Inovio Pharmaceuticals Inc INO.O:
INOVIO ANNOUNCES FAVORABLE JUDGMENT IN LITIGATION WITH VGXI, INC. AND GENEONE LIFE SCIENCE
INOVIO PHARMACEUTICALS - SECURES JUDGMENT OF $80.42 MILLION AGAINST VGXI AND GENEONE LIFE SCIENCE
INOVIO PHARMACEUTICALS - COURT AWARDS INOVIO $61.75 MILLION IN COMPENSATORY DAMAGES AND $18.67 MILLION IN FEES AND COSTS
INOVIO PHARMACEUTICALS - COURT ENTERS JUDGMENT AGAINST DEFENDANTS ON COUNTERCLAIMS
INOVIO PHARMACEUTICALS INC: DEFENDANTS' FINANCIAL CONDITION WILL LIKELY IMPAIR CO'S ABILITY TO COLLECT SOME OR ALL OF JUDGMENT
Source text: ID:nPn3BZkq0a
Further company coverage: INO.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million